Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Neurocrine Biosciences Inc. (NBIX)

-NasdaqGS
13.45 Down 0.39(2.82%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 730   729   730   730  
Cost of Revenue -   -   -   -  
Gross Profit 730   729   730   730  
Operating Expenses
Research Development8,918  9,490  10,527  10,313  
Selling General and Administrative3,342  3,245  3,370  3,392  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (11,530) (12,006) (13,167) (12,975)
Income from Continuing Operations
Total Other Income/Expenses Net888  875  925  900  
Earnings Before Interest And Taxes(10,642)(11,131)(12,242)(12,075)
Interest Expense -   -   -   -  
Income Before Tax(10,642)(11,131)(12,242)(12,075)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(10,642)(11,131)(12,242)(12,075)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (10,642) (11,131) (12,242) (12,075)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (10,642) (11,131) (12,242) (12,075)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.